Jiangsu Sihuan Bioengineering Co., Ltd (SHE:000518)

China flag China · Delayed Price · Currency is CNY
2.570
+0.020 (0.78%)
Feb 13, 2026, 3:04 PM CST
Market Cap2.65B -2.7%
Revenue (ttm)341.90M +61.7%
Net Income-108.07M
EPS-0.10
Shares Out1.03B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,204,800
Average Volume15,076,093
Open2.590
Previous Close2.550
Day's Range2.540 - 2.590
52-Week Range1.720 - 2.880
Beta0.36
RSI48.62
Earnings DateApr 18, 2026

About SHE:000518

Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers delusheng and xindelusheng, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass. It also engages in breeding and sales of flowers and seedlings; and landscaping projects. Jiangsu Sihuan Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Jiangyin, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1992
Employees 277
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000518
Full Company Profile

Financial Performance

In 2024, SHE:000518's revenue was 203.52 million, a decrease of -13.55% compared to the previous year's 235.42 million. Losses were -109.99 million, 46.1% more than in 2023.

Financial Statements